Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival (Q59487603)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 May 2005

Language	Label	Description	Also known as
English	Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival	scientific article published on 01 May 2005

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

breast carcinoma

1 reference

based on heuristic

inferred from title

author name string

Nikita Makretsov

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Erika Yorida

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Dmitry Turbin

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Karen Gelmon

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sam M Wiseman

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Torsten O Nielsen

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

David G Huntsman

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

0 references

publication date

1 May 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

103

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1770-1777

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Prognostic and predictive factors in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

The deaf and the dumb: the biology of ErbB-2 and ErbB-3

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of ErbB inhibitors in trastuzumab resistance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Co-Expression of ErbB-Family Members in Human Breast Cancer: Her-2/neu is the Preferred Dimerization Candidate in Nodal-positive Tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

HER (erbB) tyrosine kinase inhibitors in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of epidermal growth factor receptor in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of erbB/HER receptors, heregulin and P38 in primary breast cancer using quantitative immunohistochemistry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Type 1 growth factor receptor expression in node positive breast cancer: adverse prognostic significance of c-erbB-4

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erbB-4 protein expression in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Type 1 protein tyrosine kinases in Chinese breast carcinomas: a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

The FUTURE of ErbB-1 and ErbB-2 pathway inhibition in breast cancer: targeting multiple receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

CI-1033, an irreversible pan-erbB receptor inhibitor and its potential application for the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20970

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q59487603&oldid=1986778822"